DENTSPLY SIRONA (XRAY) Expected to Announce Quarterly Earnings on Thursday

DENTSPLY SIRONA (NASDAQ:XRAY) is anticipated to announce its Q3 2025 results before the market opens on Thursday, November 6th. Analysts expect the company to announce earnings of $0.45 per share and revenue of $900.3320 million for the quarter. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS.Investors may review the information on the company’s upcoming Q3 2025 earningreport for the latest details on the call scheduled for Thursday, November 6, 2025 at 8:30 AM ET.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share for the quarter, topping the consensus estimate of $0.50 by $0.02. The business had revenue of $936.00 million during the quarter, compared to the consensus estimate of $929.67 million. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. The firm’s revenue for the quarter was down 4.9% on a year-over-year basis. During the same period in the previous year, the firm posted $0.49 earnings per share. On average, analysts expect DENTSPLY SIRONA to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

DENTSPLY SIRONA Stock Performance

DENTSPLY SIRONA stock opened at $12.49 on Wednesday. The company has a quick ratio of 1.11, a current ratio of 1.69 and a debt-to-equity ratio of 1.13. The company has a market capitalization of $2.49 billion, a PE ratio of -2.64, a P/E/G ratio of 0.81 and a beta of 0.96. The firm has a fifty day simple moving average of $13.14 and a two-hundred day simple moving average of $14.52. DENTSPLY SIRONA has a twelve month low of $11.69 and a twelve month high of $24.86.

Hedge Funds Weigh In On DENTSPLY SIRONA

Hedge funds and other institutional investors have recently modified their holdings of the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in DENTSPLY SIRONA during the first quarter worth about $26,000. Pitcairn Co. bought a new stake in DENTSPLY SIRONA during the second quarter worth about $160,000. Tower Research Capital LLC TRC boosted its stake in DENTSPLY SIRONA by 26.7% during the second quarter. Tower Research Capital LLC TRC now owns 15,273 shares of the medical instruments supplier’s stock worth $243,000 after acquiring an additional 3,219 shares in the last quarter. EP Wealth Advisors LLC bought a new stake in DENTSPLY SIRONA during the second quarter worth about $244,000. Finally, Empowered Funds LLC boosted its stake in DENTSPLY SIRONA by 8.8% during the first quarter. Empowered Funds LLC now owns 16,324 shares of the medical instruments supplier’s stock worth $244,000 after acquiring an additional 1,320 shares in the last quarter. Hedge funds and other institutional investors own 95.70% of the company’s stock.

Analyst Ratings Changes

Several analysts have weighed in on XRAY shares. Needham & Company LLC reissued a “hold” rating on shares of DENTSPLY SIRONA in a research note on Friday, September 26th. Wall Street Zen cut shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Saturday, October 18th. Barrington Research restated an “outperform” rating and issued a $18.00 price objective on shares of DENTSPLY SIRONA in a research report on Wednesday, October 29th. UBS Group decreased their price objective on shares of DENTSPLY SIRONA from $24.00 to $23.00 and set a “buy” rating on the stock in a research report on Tuesday, October 28th. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of DENTSPLY SIRONA in a research report on Wednesday, October 8th. Two analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $17.91.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.